600201.SS · 生物股份
China A-shares · RS rating 65 · As of 2026-10-14
| Price | 12.22 CNY |
|---|---|
| 1-day change | +2.4% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 74 / 52 / 88 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 32 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +18.3% |
| Distance from 52-week high | +34.9% |
| Market cap (USD) | $1.9B |